Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Oncology Drugs is widely used For Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/Lung Cancer and Other Cancer Treatment. The most proportion of Oncology Drugs used for Blood Cancer and the proportion in 2019 is 22%. Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
The report details the trend, potential and market size of Oncology/Cancer Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Oncology/Cancer Drugsmarket, defines the market attractiveness level of Oncology/Cancer Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Oncology/Cancer Drugs industry, describes the types of Oncology/Cancer Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Oncology/Cancer Drugs market and the development prospects and opportunities of Oncology/Cancer Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Oncology/Cancer Drugs market in Chapter 13.
By Player:
Roche
LUYE
AstraZeneca
HANSOH
QILU
Lunan
Novartis
Eli Lilly and Company
HENGRUI
Sanofi
GuiZhou YiBai
By Type:
Antimetabolite
Alkaloid Drugs
Hormone
Targeted Drug
Platinum-based Drugs
Other
By End-User:
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Oncology/Cancer Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Oncology/Cancer Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Oncology/Cancer Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Oncology/Cancer Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Oncology/Cancer Drugs Market Analysis and Outlook to 2022
-
7.1 Global Oncology/Cancer Drugs Consumption (2017-2022)
-
7.2 United States Oncology/Cancer Drugs Consumption (2017-2022)
-
7.3 Europe Oncology/Cancer Drugs Consumption (2017-2022)
-
7.4 China Oncology/Cancer Drugs Consumption (2017-2022)
-
7.5 Japan Oncology/Cancer Drugs Consumption (2017-2022)
-
7.6 India Oncology/Cancer Drugs Consumption (2017-2022)
-
7.7 South Korea Oncology/Cancer Drugs Consumption (2017-2022)
8 Region and Country-wise Oncology/Cancer Drugs Market Analysis and Outlook to 2028
-
8.1 Global Oncology/Cancer Drugs Consumption Forecast (2022-2028)
-
8.2 United States Oncology/Cancer Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Oncology/Cancer Drugs Consumption Forecast (2022-2028)
-
8.4 China Oncology/Cancer Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Oncology/Cancer Drugs Consumption Forecast (2022-2028)
-
8.6 India Oncology/Cancer Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Oncology/Cancer Drugs Consumption Forecast (2022-2028)
9 Global Oncology/Cancer Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Oncology/Cancer Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Antimetabolite Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Alkaloid Drugs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Hormone Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Targeted Drug Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Platinum-based Drugs Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Oncology/Cancer Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Blood Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Gastrointestinal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Respiratory/Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Other Consumption and Growth Rate (2017-2022)
10 Global Oncology/Cancer Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Oncology/Cancer Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Antimetabolite Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Alkaloid Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Hormone Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Targeted Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Platinum-based Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Oncology/Cancer Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Gastrointestinal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Respiratory/Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Oncology/Cancer Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Oncology/Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Oncology/Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Oncology/Cancer Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Oncology/Cancer Drugs Market Competitive Analysis
-
14.1 Roche
-
14.1.1 Roche Company Details
-
14.1.2 Roche Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Roche Oncology/Cancer Drugs Product and Service
-
14.2 LUYE
-
14.2.1 LUYE Company Details
-
14.2.2 LUYE Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 LUYE Oncology/Cancer Drugs Product and Service
-
14.3 AstraZeneca
-
14.3.1 AstraZeneca Company Details
-
14.3.2 AstraZeneca Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AstraZeneca Oncology/Cancer Drugs Product and Service
-
14.4 HANSOH
-
14.4.1 HANSOH Company Details
-
14.4.2 HANSOH Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 HANSOH Oncology/Cancer Drugs Product and Service
-
14.5 QILU
-
14.5.1 QILU Company Details
-
14.5.2 QILU Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 QILU Oncology/Cancer Drugs Product and Service
-
14.6 Lunan
-
14.6.1 Lunan Company Details
-
14.6.2 Lunan Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Lunan Oncology/Cancer Drugs Product and Service
-
14.7 Novartis
-
14.7.1 Novartis Company Details
-
14.7.2 Novartis Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis Oncology/Cancer Drugs Product and Service
-
14.8 Eli Lilly and Company
-
14.8.1 Eli Lilly and Company Company Details
-
14.8.2 Eli Lilly and Company Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Eli Lilly and Company Oncology/Cancer Drugs Product and Service
-
14.9 HENGRUI
-
14.9.1 HENGRUI Company Details
-
14.9.2 HENGRUI Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 HENGRUI Oncology/Cancer Drugs Product and Service
-
14.10 Sanofi
-
14.10.1 Sanofi Company Details
-
14.10.2 Sanofi Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Sanofi Oncology/Cancer Drugs Product and Service
-
14.11 GuiZhou YiBai
-
14.11.1 GuiZhou YiBai Company Details
-
14.11.2 GuiZhou YiBai Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 GuiZhou YiBai Oncology/Cancer Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Oncology/Cancer Drugs
-
Figure Oncology/Cancer Drugs Picture
-
Table Global Oncology/Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oncology/Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oncology/Cancer Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Oncology/Cancer Drugs Consumption by Country (2017-2022)
-
Figure United States Oncology/Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Oncology/Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Oncology/Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Oncology/Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Oncology/Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Oncology/Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology/Cancer Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Oncology/Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Oncology/Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Oncology/Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Oncology/Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Oncology/Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Oncology/Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antimetabolite Consumption and Growth Rate (2017-2022)
-
Figure Global Alkaloid Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hormone Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Platinum-based Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory/Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Antimetabolite Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alkaloid Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hormone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Platinum-based Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastrointestinal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory/Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Oncology/Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Oncology/Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Oncology/Cancer Drugs Product and Service
-
Table LUYE (Foundation Year, Company Profile and etc.)
-
Table LUYE Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table LUYE Oncology/Cancer Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Oncology/Cancer Drugs Product and Service
-
Table HANSOH (Foundation Year, Company Profile and etc.)
-
Table HANSOH Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table HANSOH Oncology/Cancer Drugs Product and Service
-
Table QILU (Foundation Year, Company Profile and etc.)
-
Table QILU Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table QILU Oncology/Cancer Drugs Product and Service
-
Table Lunan (Foundation Year, Company Profile and etc.)
-
Table Lunan Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lunan Oncology/Cancer Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Oncology/Cancer Drugs Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Oncology/Cancer Drugs Product and Service
-
Table HENGRUI (Foundation Year, Company Profile and etc.)
-
Table HENGRUI Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table HENGRUI Oncology/Cancer Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Oncology/Cancer Drugs Product and Service
-
Table GuiZhou YiBai (Foundation Year, Company Profile and etc.)
-
Table GuiZhou YiBai Oncology/Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GuiZhou YiBai Oncology/Cancer Drugs Product and Service
-
